""	"curation_date"	"cohort"	"subgroup"	"age_group"	"age_min"	"age_max"	"age_units"	"number_subjects"	"tissue_type"	"method"	"response_component_original"	"response_behavior_type"	"response_behavior"	"comparison"	"baseline_time_event"	"time_point"	"time_point_units"	"exposure_material_id"	"additional_exposure_material"	"target_pathogen"	"vaccine_year"	"adjuvant"	"route"	"scheduling"	"publication_reference_id"	"publication_year"	"publication_reference_url"	"signature_source"	"signature_source_url"	"comments"	"cell_ontology_id"	"proterm_and_extra"	"pro_ontology_id"	"fully_qualified_response_component"	"response_component"	"submission_name"	"submission_date"	"template_name"	"response_comp_orig_cnt"	"response_comp_cnt"	"subm_obs_id"	"uniq_obs_id"	"row_key"	"signature_file"
"subject"	""	""	""	""	""	""	""	""	"cell_subset"	""	""	""	""	""	""	""	""	"vaccine"	""	"pathogen"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"file"
"role"	"background"	"observed"	"background"	"observed"	"observed"	"observed"	"observed"	"observed"	"tissue"	"observed"	"observed"	"background"	"measured"	"background"	"background"	"observed"	"observed"	"vaccine"	"background"	"pathogen"	"background"	"background"	"background"	"background"	"background"	"background"	"reference"	"background"	"background"	"background"	"observed"	"observed"	"observed"	"observed"	""	"background"	"background"	"background"	"observed"	"observed"	"background"	"background"	"background"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	"curation date"	"cohort"	"subgroup"	"age group"	"age min."	"age max."	"age units"	"number of subjects"	"tissue type"	"primary experimental method used to measure the response"	"response component (original cell type)"	"response behavior type"	"response behavior"	"comparison"	"baseline time"	"time point"	"time point units"	"exposure material (VO)"	"exposure material - additional"	"target pathogen"	"vaccine year"	"adjuvant"	"route"	"scheduling"	"publication reference (PMID)"	"print publication year"	"Sobolev et al. (2016) Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=26726811' target='_blank'>26726811</a>"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	"cell ontology ID"	"cell type PRO and extra terms"	"protein ontology ID"	"all response components in signature"	""	"submission name"	"submission_date"	"template_name"	"response component (original) count"	"response component count"	"ID of observation within its own submission"	"Uniq ID of observation within its submission type"	"row key"	"response component (cell types) file"
""	""	"adults (18-64)"	"none"	"adults, seniors"	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	""	"CD45RO+ CCR7+ central memory CD4 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"14"	"days"	"VO_0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM' target='_blank'>#SM</a>"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	"CL_0000904"	"& CD45RO+, CCR7+"	"PR_000001017, PR_000001203"	"central memory CD4-positive, alpha-beta T cell & CD45RO+, CCR7+"	"central memory CD4-positive, alpha-beta T cell"	"hipc_ctf_26726811_18"	"2016.01.05"	"hipc_ctf_26726811_18"	"2"	"2"	"18"	"189"	"26726811_18_189"	"hipc_ctf_sig_26726811_18.txt"
""	""	"adults (18-64)"	"none"	"adults, seniors"	"18"	"64"	"years"	"178"	"peripheral blood mononuclear cell"	""	"CD45RO+ CCR7+ central memory CD8 cells"	"cell type frequency"	"up"	"<35yr old vs >35yr old"	"time of vaccination (first dose)"	"14"	"days"	"VO_0000410"	""	"influenza A virus (A/California/7/2009(H1N1))"	"pan"	"AS03 (GSK)"	""	""	"26726811"	"2016"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/"	"Suppl Fig 5C"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM' target='_blank'>#SM</a>"	"- roughly 60/40 female:male ratio, over 70% were Causasian"	"CL_0000907"	"& CD45RO+, CCR7+"	"PR_000001017, PR_000001203"	"central memory CD8-positive, alpha-beta T cell & CD45RO+, CCR7+"	"central memory CD8-positive, alpha-beta T cell"	"hipc_ctf_26726811_18"	"2016.01.05"	"hipc_ctf_26726811_18"	"2"	"2"	"18"	"189"	"26726811_18_189"	"hipc_ctf_sig_26726811_18.txt"
